Cardioprotective Effect of Insulin-like Growth Factor I in Myocardial Ischemia Followed by Reperfusion

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1995 Aug 15

PMID 7644533

Citations 80

Authors

M Buerke

T Murohara

C Skurk

C Nuss

K Tomaselli

A M Lefer

Affiliations

Soon will be listed here.

Abstract

In the present study, the cardioprotective effects of insulin-like growth factor I (IGF-I) were examined in a murine model of myocardial ischemia reperfusion (i.e., 20 min + 24 hr). IGF-I (1-10 micrograms per rat) administered 1 hr prior to ischemia significantly attenuated myocardial injury (i.e., creatine kinase loss) compared to vehicle (P < 0.001). In addition, cardiac myeloperoxidase activity, an index of neutrophil accumulation, in the ischemic area was significantly attenuated by IGF-I (P < 0.001). This protective effect of IGF-I was not observed with des-(1-3)-IGF-I. Immunohistochemical analysis of ischemic-reperfused myocardial tissue demonstrated markedly increased DNA fragmentation due to programmed cell death (i.e., apoptosis) compared to nonischemic myocardium. Furthermore, IGF-I significantly attenuated the incidence of myocyte apoptosis after myocardial ischemia and reperfusion. Therefore, IGF-I appears to be an effective agent for preserving ischemic myocardium from reperfusion injury and protects via two different mechanisms--inhibition of polymorphonuclear leukocyte-induced cardiac necrosis and inhibition of reperfusion-induced apoptosis of cardiac myocytes.

Citing Articles

Insulin-like growth factor-1 in myocardial ischemia-reperfusion injury: A review.

Yan Z, Xing Z, Xue T, Zhao J, Li G, Xu L Medicine (Baltimore). 2024; 103(9):e37279.

PMID: 38428899 PMC: 10906579. DOI: 10.1097/MD.0000000000037279.

Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.

Kumar K, Singh N, Yadav H, Maslov L, Jaggi A Curr Cardiol Rev. 2023; 19(6):56-71.

PMID: 37309766 PMC: 10636797. DOI: 10.2174/1573403X19666230612112259.

Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?.

Kukreja R, Wang R, Koka S, Das A, Samidurai A, Xi L Mol Cell Biochem. 2022; 478(3):679-696.

PMID: 36036333 PMC: 9421626. DOI: 10.1007/s11010-022-04520-2.

Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction.

Nederlof R, Reidel S, Spychala A, Godecke S, Heinen A, Lautwein T Front Immunol. 2022; 13:908023.

PMID: 35911749 PMC: 9334797. DOI: 10.3389/fimmu.2022.908023.

Echocardiographic findings in acromegaly: prevalence of concentric left ventricular remodeling in a large single-center cohort.

Hinojosa-Amaya J, Varlamov E, Yedinak C, Cetas J, McCartney S, Banskota S J Endocrinol Invest. 2021; 44(12):2665-2674.

PMID: 33893617 DOI: 10.1007/s40618-021-01579-4.

References

Barres B, Hart I, Coles H, Burne J, Voyvodic J, Richardson W . Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 1992; 70(1):31-46. DOI: 10.1016/0092-8674(92)90531-g. View

Rosalki S . An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967; 69(4):696-705. View

Bradley P, Priebat D, Christensen R, ROTHSTEIN G . Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982; 78(3):206-9. DOI: 10.1111/1523-1747.ep12506462. View

FROESCH E, Schmid C, Schwander J, Zapf J . Actions of insulin-like growth factors. Annu Rev Physiol. 1985; 47:443-67. DOI: 10.1146/annurev.ph.47.030185.002303. View

Mullane K, Kraemer R, Smith B . Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985; 14(3):157-67. DOI: 10.1016/0160-5402(85)90029-4. View

Radomski M, Palmer R, Moncada S . Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987; 92(1):181-7. PMC: 1853617. DOI: 10.1111/j.1476-5381.1987.tb11310.x. View

Arends M, Morris R, Wyllie A . Apoptosis. The role of the endonuclease. Am J Pathol. 1990; 136(3):593-608. PMC: 1877493. View

Lefer A, Tsao P, Aoki N, Palladino Jr M . Mediation of cardioprotection by transforming growth factor-beta. Science. 1990; 249(4964):61-4. DOI: 10.1126/science.2164258. View

Tsao P, Aoki N, Lefer D, Johnson 3rd G, Lefer A . Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990; 82(4):1402-12. DOI: 10.1161/01.cir.82.4.1402. View

10.

Haylor J, Singh I, El Nahas A . Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int. 1991; 39(2):333-5. DOI: 10.1038/ki.1991.42. View

11.

Kubes P, Suzuki M, Granger D . Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991; 88(11):4651-5. PMC: 51723. DOI: 10.1073/pnas.88.11.4651. View

12.

Butcher E . Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991; 67(6):1033-6. DOI: 10.1016/0092-8674(91)90279-8. View

13.

Rubanyi G, Ho E, Cantor E, Lumma W, Botelho L . Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 1991; 181(3):1392-7. DOI: 10.1016/0006-291x(91)92093-y. View

14.

Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M . A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun. 1992; 182(2):593-9. DOI: 10.1016/0006-291x(92)91774-k. View

15.

Raff M . Social controls on cell survival and cell death. Nature. 1992; 356(6368):397-400. DOI: 10.1038/356397a0. View

16.

LeRoith D, Clemmons D, Nissley P, Rechler M . NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med. 1992; 116(10):854-62. DOI: 10.7326/0003-4819-116-10-854. View

17.

Siegfried M, Carey C, Ma X, Lefer A . Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol. 1992; 263(3 Pt 2):H771-7. DOI: 10.1152/ajpheart.1992.263.3.H771. View

18.

Kukreja R, Hess M . The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res. 1992; 26(7):641-55. DOI: 10.1093/cvr/26.7.641. View

19.

Ma X, Weyrich A, Lefer D, Lefer A . Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993; 72(2):403-12. DOI: 10.1161/01.res.72.2.403. View

20.

Lefer A, Ma X . Cytokines and growth factors in endothelial dysfunction. Crit Care Med. 1993; 21(2 Suppl):S9-14. DOI: 10.1097/00003246-199302001-00003. View